Curriculum Vitae Meng Dong, PhD
Affiliation
Postdoctoral fellow at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 2070
fax: ++49-711-859295
email: meng.dong@ikp-stuttgart.de
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 2070
fax: ++49-711-859295
email: meng.dong@ikp-stuttgart.de
Dr. rer. nat. Meng Dong
phone: ++49-711-8101 3758
Education and Professional Career
1998-2003 | Bachelor of Medical Science, West China Medical Center of Sichuan University, China |
2004-2006 | M.Sc. of Molecular Bioengineering, TU Dresden, Germany |
2007-2011 | PhD at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen with cooperation of Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Germany |
2011-present | Postdoctoral fellow at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Germany Research Area: Tissue slice culture as preclinical models for personalized medicine |
Selected References
- Dong M, Mürdter TE, Philippi C, Loretz B, Schaefer UF, Lehr CM, Schwab M, Ammon-Treiber S. Pulmonary delivery and tissue distribution of aerosolized antisense 2'-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung. Eur J Pharm Biopharm. 2012 Aug;81(3):478-85. doi: 10.1016/j.ejpb.2012.04.022.
- Dong M, Philippi C, Loretz B, Nafee N, Schaefer UF, Friedel G, Ammon-Treiber S, Griese EU, Lehr CM, Klotz U, Mürdter TE. Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2´-O-methyl-RNA. Int J Pharm.2011 Oct 31;419(1-2):33-42
- Beisner J, Dong M, Taetz S, Nafee N, Griese EU, Schaefer UF, Lehr CM, Klotz U, Mürdter TE. Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells. Lung Cancer. 2010 Jun; 68(3):346-54.
- Beisner J, Dong M, Taetz S, Piotrowska K, Kleideiter E, Friedel G, Schaefer UF, Lehr CM, Klotz U, Mürdter TE. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA. J Pharm Sci. 2009 May; 98(5):1765-74.